Works matching AU Lai, Ching Lung


Results: 149
    1
    2
    3
    4
    5
    6

    Hepatitis B core protein as a therapeutic target.

    Published in:
    Expert Opinion on Therapeutic Targets, 2017, v. 21, n. 12, p. 1153, doi. 10.1080/14728222.2017.1397134
    By:
    • Mak, Lung-Yi;
    • Wong, Danny Ka-Ho;
    • Seto, Wai-Kay;
    • Lai, Ching-Lung;
    • Yuen, Man Fung
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    HEPATITIS B VIRUS INFECTION IN CHINESE FAMILIES IN HONGKONG.

    Published in:
    American Journal of Epidemiology, 1987, v. 126, n. 3, p. 492, doi. 10.1093/oxfordjournals.aje.a114681
    By:
    • LOK, ANNA SUK-FONG;
    • LAI, CHING-LUNG;
    • WU, PUI-CHEE;
    • WONG, VIVIAN CHIWOON;
    • YEOH, ENG-KIANG;
    • LIN, HSIANG-JU
    Publication type:
    Article
    23

    A case–control study of response to lamivudine therapy for 2 years in Japanese and Chinese patients chronically infected with hepatitis B virus of genotypes Bj, Ba and C

    Published in:
    Hepatology Research, 2006, v. 35, n. 2, p. 127, doi. 10.1016/j.hepres.2006.03.005
    By:
    • Orito, Etsuro;
    • Fujiwara, Kei;
    • Tanaka, Yasuhito;
    • Yuen, Man-Fung;
    • Lai, Ching-Lung;
    • Kato, Takanobu;
    • Sugauchi, Fuminaka;
    • Kusakabe, Atsunori;
    • Sata, Michio;
    • Okanoue, Takeshi;
    • Niitsuma, Hirofumi;
    • Sakugawa, Hiroshi;
    • Hasegawa, Izumi;
    • Mizokami, Masashi
    Publication type:
    Article
    24
    25
    26
    27
    28

    Mutational analysis of 65 Wilson disease patients in Hong Kong Chinese: Identification of 17 novel mutations and its genetic heterogeneity.

    Published in:
    Journal of Human Genetics, 2008, v. 53, n. 1, p. 55, doi. 10.1007/s10038-007-0218-2
    By:
    • Miu Mak, Chloe;
    • Ching-Wan Lam;
    • Tam, Sidney;
    • Ching-Lung Lai;
    • Lik-Yuen Chan;
    • Sheung-Tat Fan;
    • Yu-Lung Lau;
    • Jak-Yiu Lai;
    • Yuen, Patrick;
    • Hui, Joannie;
    • Chun-Cheung Fu;
    • Ka-Sing Wong;
    • Wing-Lai Mak;
    • Kong Tze;
    • Sui-Fan Tong;
    • Lau, Abby;
    • Leung, Nancy;
    • Hui, Aric;
    • Ka-Ming Cheung;
    • Chun-Hung Ko
    Publication type:
    Article
    29

    Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2019, v. 38, n. 1, p. N.PAG, doi. 10.1186/s13046-019-1402-x
    By:
    • Leung, Zoe;
    • Ko, Frankie Chi Fat;
    • Tey, Sze Keong;
    • Kwong, Ernest Man Lok;
    • Mao, Xiaowen;
    • Liu, Bonnie Hei Man;
    • Ma, Angel Po Yee;
    • Fung, Yi Man Eva;
    • Che, Chi-Ming;
    • Wong, Danny Ka Ho;
    • Lai, Ching Lung;
    • Ng, Irene Oi-Lin;
    • Yam, Judy Wai Ping
    Publication type:
    Article
    30

    Reply to Liao et al.

    Published in:
    Clinical Infectious Diseases, 2013, v. 57, n. 4, p. 622, doi. 10.1093/cid/cit295
    By:
    • Seto, Wai-Kay;
    • Wong, Danny Ka-Ho;
    • Lai, Ching-Lung;
    • Yuen, Man-Fung
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50